These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88. Preprocedural platelet transfusion for patients with thrombocytopenia undergoing interventional radiology procedures is not associated with reduced bleeding complications. Warner MA; Woodrum D; Hanson A; Schroeder DR; Wilson G; Kor DJ Transfusion; 2017 Apr; 57(4):890-898. PubMed ID: 28130779 [TBL] [Abstract][Full Text] [Related]
89. Role of donor and recipient sex in platelet transfusion. Stern M; Infanti L; O'Meara A; Sigle J; Buser A Transfusion; 2013 Nov; 53(11):2801-6. PubMed ID: 23451819 [TBL] [Abstract][Full Text] [Related]
90. Efficacy of HPA-1a (PlA1)-negative platelets in a patient with post-transfusion purpura. Loren AW; Abrams CS Am J Hematol; 2004 Jul; 76(3):258-62. PubMed ID: 15224362 [TBL] [Abstract][Full Text] [Related]
91. Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report. Macher S; Schallmoser K; Staber PB; Neumeister P; Posch U; Lanzer G; Panzer S Vox Sang; 2005 Nov; 89(4):257-60. PubMed ID: 16262760 [TBL] [Abstract][Full Text] [Related]
92. Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Tanaka KA; Egan K; Szlam F; Ogawa S; Roback JD; Sreeram G; Guyton RA; Chen EP Transfusion; 2014 Jan; 54(1):109-18. PubMed ID: 23718572 [TBL] [Abstract][Full Text] [Related]
93. How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets? Fontaine MJ; Webster J; Gomez S; Pham TD; Goodnough LT; Galel SA Transfusion; 2015 Dec; 55(12):2783-9. PubMed ID: 26448376 [TBL] [Abstract][Full Text] [Related]
94. Using lean techniques to define the platelet (PLT) transfusion process and cost-effectiveness to evaluate PLT dose transfusion strategies. Riley W; Smalley B; Pulkrabek S; Clay ME; McCullough J Transfusion; 2012 Sep; 52(9):1957-67. PubMed ID: 22320153 [TBL] [Abstract][Full Text] [Related]
95. Post-transfusion increment of platelet count in thrombocytopenic patients treated with platelet concentrates. Hoque MM; Rahman M; Rahman SM; Habibullah MM; Faruki MA; Rahman KH; Mamun AA; Hossain MA Mymensingh Med J; 2013 Jan; 22(1):64-8. PubMed ID: 23416811 [TBL] [Abstract][Full Text] [Related]
96. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Daniel-Johnson J; Leitman S; Klein H; Alter H; Lee-Stroka A; Scheinberg P; Pantin J; Quillen K Transfusion; 2009 Sep; 49(9):1845-9. PubMed ID: 19453987 [TBL] [Abstract][Full Text] [Related]
97. Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation. Fayed NA; Abdallah AR; Khalil MK; Marwan IK Platelets; 2014; 25(8):576-86. PubMed ID: 24246132 [TBL] [Abstract][Full Text] [Related]
98. Anti-E alloimmunization from a platelet apheresis transfusion in a 22-month-old male with acute myeloid leukemia. Burks M; Warren CS; Lightfoot T; Fadeyi EA Lab Med; 2024 Jul; 55(4):517-519. PubMed ID: 38346103 [TBL] [Abstract][Full Text] [Related]
99. Neonatal thrombocytopenia caused by passive transfer of anti-PLA1 antibody by blood transfusion. Marzich C; Strohm PL; Ayas M; Cochran RK J Pediatr; 1996 Jan; 128(1):137-9. PubMed ID: 8551405 [TBL] [Abstract][Full Text] [Related]
100. An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients. Lieberman L; Liu Y; Portwine C; Barty RL; Heddle NM Transfusion; 2014 Oct; 54(10 Pt 2):2736-44. PubMed ID: 24773382 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]